M
Michihiko Goto
Researcher at Roy J. and Lucille A. Carver College of Medicine
Publications - 76
Citations - 1369
Michihiko Goto is an academic researcher from Roy J. and Lucille A. Carver College of Medicine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 10, co-authored 51 publications receiving 992 citations. Previous affiliations of Michihiko Goto include Veterans Health Administration & University of Iowa.
Papers
More filters
Journal ArticleDOI
Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe
TL;DR: There is a need for a greater focus on BSI research in order to reduce the overall burden of disease by improving the outcome of patients with BSI and the role of infection control and prevention methods in reducing the burden of nosocomial BSI.
Journal ArticleDOI
Comparative Effectiveness of Beta-lactams versus Vancomycin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections among 122 Hospitals
Jennifer S. McDanel,Eli N. Perencevich,Daniel J. Diekema,Loreen A. Herwaldt,Tara C. Smith,Elizabeth A. Chrischilles,Jeffrey D. Dawson,Lan Jiang,Michihiko Goto,Marin L. Schweizer +9 more
TL;DR: For patients with MSSA bloodstream infections, beta-lactams are superior to vancomycin for definitive therapy but not for empiric treatment, specifically antistaphylococcal penicillins or cefazolin.
Journal ArticleDOI
Accuracy of Administrative Code Data for the Surveillance of Healthcare-Associated Infections: A Systematic Review and Meta-Analysis
Michihiko Goto,Michael E. Ohl,Marin L. Schweizer,Marin L. Schweizer,Eli N. Perencevich,Eli N. Perencevich +5 more
TL;DR: Evidence for the accuracy of ACD for the detection of selected HAIs, including catheter-associated urinary tract infection, Clostridium difficile infection (CDI), central line-associated bloodstream infection, ventilator-associated pneumonia/events, postprocedure pneumonia, and surgical site infections is summarized.
Journal ArticleDOI
Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.
Jennifer S. McDanel,Jennifer S. McDanel,Jennifer S. McDanel,Mary-Claire Roghmann,Mary-Claire Roghmann,Eli N. Perencevich,Eli N. Perencevich,Eli N. Perencevich,Michael E. Ohl,Michael E. Ohl,Michihiko Goto,Michihiko Goto,Daniel J Livorsi,Daniel J Livorsi,Makoto Jones,Makoto Jones,Justin Albertson,Rajeshwari Nair,Rajeshwari Nair,Amy M.J. O'Shea,Amy M.J. O'Shea,Marin L. Schweizer,Marin L. Schweizer,Marin L. Schweizer +23 more
TL;DR: Patients who received cefazolin had a lower risk of mortality and similar odds of recurrent infections compared with nafcillin or oxacillin for MSSA infections complicated by bacteremia.
Journal ArticleDOI
Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014
Michihiko Goto,Michihiko Goto,Marin L. Schweizer,Marin L. Schweizer,Mary Vaughan-Sarrazin,Mary Vaughan-Sarrazin,Eli N. Perencevich,Eli N. Perencevich,Daniel J Livorsi,Daniel J Livorsi,Daniel J. Diekema,Kelly Richardson,Brice Beck,Bruce Alexander,Michael E. Ohl,Michael E. Ohl +15 more
TL;DR: Mortality associated with S aureus bacteremia decreased significantly in VHA hospitals, and a substantial portion of the decreasing mortality may have been attributable to increased use of evidence-based care processes.